These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 24288554)
1. CD8 knockout mice are protected from challenge by vaccination with WR201, a live attenuated mutant of Brucella melitensis. Yingst SL; Izadjoo M; Hoover DL Clin Dev Immunol; 2013; 2013():686919. PubMed ID: 24288554 [TBL] [Abstract][Full Text] [Related]
2. Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK). Hoover DL; Crawford RM; Van De Verg LL; Izadjoo MJ; Bhattacharjee AK; Paranavitana CM; Warren RL; Nikolich MP; Hadfield TL Infect Immun; 1999 Nov; 67(11):5877-84. PubMed ID: 10531243 [TBL] [Abstract][Full Text] [Related]
3. The candidate vaccine strain Brucella ovis ∆abcBA is protective against Brucella melitensis infection in mice. Costa LF; Cabello AL; Batista DFA; Chaki SP; de Figueiredo P; da Paixão TA; Rice-Ficht AC; Ficht TA; Santos RL Microbiol Immunol; 2020 Nov; 64(11):730-736. PubMed ID: 32965738 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis. Al-Mariri A; Abbady AQ J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643 [TBL] [Abstract][Full Text] [Related]
9. Comparison of protective efficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Bhattacharjee AK; Izadjoo MJ; Zollinger WD; Nikolich MP; Hoover DL Infect Immun; 2006 Oct; 74(10):5820-5. PubMed ID: 16988260 [TBL] [Abstract][Full Text] [Related]
10. A study on the use of male animal models for developing a live vaccine for brucellosis. Izadjoo MJ; Mense MG; Bhattacharjee AK; Hadfield TL; Crawford RM; Hoover DL Transbound Emerg Dis; 2008 May; 55(3-4):145-51. PubMed ID: 18405337 [TBL] [Abstract][Full Text] [Related]
11. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant. Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131 [TBL] [Abstract][Full Text] [Related]
12. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice. Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316 [TBL] [Abstract][Full Text] [Related]
13. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4+ T helper 1 response that protects against Brucella melitensis infection. Cassataro J; Estein SM; Pasquevich KA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH Infect Immun; 2005 Dec; 73(12):8079-88. PubMed ID: 16299302 [TBL] [Abstract][Full Text] [Related]
14. Humoral immunity and CD4+ Th1 cells are both necessary for a fully protective immune response upon secondary infection with Brucella melitensis. Vitry MA; Hanot Mambres D; De Trez C; Akira S; Ryffel B; Letesson JJ; Muraille E J Immunol; 2014 Apr; 192(8):3740-52. PubMed ID: 24646742 [TBL] [Abstract][Full Text] [Related]
16. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats. Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541 [TBL] [Abstract][Full Text] [Related]
17. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection. Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111 [TBL] [Abstract][Full Text] [Related]
18. Induction of specific cell-mediated immune responses and protection in BALB/c mice by vaccination with outer membrane vesicles from a Brucella melitensis human isolate. Bagheri Nejad R; Yahyaraeyat R; Es-Haghi A; Nayeri Fasaei B; Zahraei Salehi T APMIS; 2019 Dec; 127(12):797-804. PubMed ID: 31514254 [TBL] [Abstract][Full Text] [Related]
19. Protective role of antibodies induced by Brucella melitensis B115 against B. melitensis and Brucella abortus infections in mice. Adone R; Francia M; Pistoia C; Petrucci P; Pesciaroli M; Pasquali P Vaccine; 2012 Jun; 30(27):3992-5. PubMed ID: 22521283 [TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice. Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]